IC6-7 Seizures and epilepsy Flashcards
4 main etiology of acute symptomatic seizures
- Metabolic
- Drugs/toxic substances
- Structural
- CNS infection
Metabolic etiology of acute symptomatic seizures
Na: hyponatremia
Ca: hypocalcemia
Mg: hypomagnesemia
Glucose: hypoglycemia
Drugs/toxic substances etiology of acute symptomatic seizures
Benzodiazepine withdrawals
Alcohol
illicit drugs
Structural etiology of acute symptomatic seizures
Trauma
Stroke
CNS infection etiology of acute symptomatic seizure
Febrile illness
CNS infection
Drug induced seizures
Antibiotics: beta lactams, carbapenems, cefepime, levofloxacin, erythromycin
Analgesics: NSAIDS, tramdol
Antipsychotics + lithium
Antidepressants: TCA, SSRI, bupropion
Clinical presentation of focal onset seizures
Clonic movements like jerking
Dysarthria: speech arrest
Numbness, tingling, visual disturbances, rising epigastric sensation
Flashbacks: deja vu, hallucinations
Fear, anger, irritation
Clinical presentation of Tonic clonic seizures
Tonic: stiff posture, loss of consciousness, decreased breathing
Clonic: Jerking of limbs
Cyanosis of nail bed, incontinence, biting of tongue,
Clinical presentation of absence seizure
Lapse in awareness, more common in children
Clinical presentation of atonic seizure
Lose all postural tone, collapse to ground
Common in Lennox Gastaut syndrome
Lab test for epilepsy
Scalp EEG epileptiform discharges confirms diagnosis of epilepsy, but not all have abnormal EEG
Non pharm treatment of epilepsy
Ketogenic diet to prevetn seizures: low carb, high fat
Seizure dairy: trigger, frequency, duration, ADR from antiseizure medications
Indications for carbamazepine
GTC, Focal seizures
ADR of Carbamazepine
CNS: Dizziness, visual disturbances, nystagmus
Hepatotoxic
Blood dyscrasias
Hyponatremia
Osteoporosis
Peripheral neuropathy
PG testing for carbamazepine
HLA B* 15:02
SJS/TEN
Cross reactive with aromatic ASM: phenytoin, phenobarbital, lamotrigine
Monitoring for carbamazepine
LFT
Full blood count
Serum sodium
Bone mineral density
DDI of carbamazepine
Inducer of 1A2, 2C9, 2C19, 3A4, UGT
Indication for sodium valproate
All types of seizures
ADR of valproate
Hepatotoxicity
Blood dyscrasias
Pancreatitis
Alopecia
Reversible weight gain
Teratogenic
Monitoring for valproate
LFT
Full blood count
DDI of valproate
Inhibitor of 2C9, UGT, epoxide hydrolase
Indication for phenytoin
GTC, Focal seizures
ADR of phenytoin
Hepatoxicity
Blood dyscrasias
Dyskinesia
Gum hyperplasia
Hirsutism
Osteoporosis
Peripheral neuropathy
Monitoring for phenytoin
LFT
Full blood count
TDM